157 related articles for article (PubMed ID: 9669863)
21. Differential expression of surface glycoconjugates on Entamoeba histolytica and Entamoeba dispar.
Pacheco-Yépez J; Campos-Rodríguez R; Rojas-Hernández S; Serrano-Luna JJ; Rivera-Aguilar V; Villa-Treviño S; Martínez-Palomo A; Tsutsumi V; Shibayama M
Parasitol Int; 2009 Jun; 58(2):171-7. PubMed ID: 19269346
[TBL] [Abstract][Full Text] [Related]
22. Comparative ultrastructural studies of the cell surface and endocytic vacuoles of Entamoeba histolytica Schaudinn, 1903 and Entamoeba dispar Brumpt, 1925.
Pimenta PF; Diamond LS
Arch Med Res; 1997; 28 Spec No():113-5. PubMed ID: 9033034
[No Abstract] [Full Text] [Related]
23. Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids.
Moody S; Becker S; Nuchamowitz Y; Mirelman D
Parasitology; 1997 Feb; 114 ( Pt 2)():95-104. PubMed ID: 9051918
[TBL] [Abstract][Full Text] [Related]
24. Erythrophagocytosis in Entamoeba histolytica and Entamoeba dispar: a comparative study.
Talamás-Lara D; Chávez-Munguía B; González-Robles A; Talamás-Rohana P; Salazar-Villatoro L; Durán-Díaz Á; Martínez-Palomo A
Biomed Res Int; 2014; 2014():626259. PubMed ID: 25003123
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
Ximénez C; González E; Nieves M; Magaña U; Morán P; Gudiño-Zayas M; Partida O; Hernández E; Rojas-Velázquez L; García de León MC; Maldonado H
PLoS One; 2017; 12(8):e0181962. PubMed ID: 28771523
[TBL] [Abstract][Full Text] [Related]
26. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity.
Nickel R; Ott C; Dandekar T; Leippe M
Eur J Biochem; 1999 Nov; 265(3):1002-7. PubMed ID: 10518795
[TBL] [Abstract][Full Text] [Related]
27. [An in vitro model for the quantitative study of E. histolytica virulence].
Orozco E; Martínez-Palomo A; Lopez-Revilla R
Arch Invest Med (Mex); 1978; 9 Suppl 1():257-60. PubMed ID: 211959
[TBL] [Abstract][Full Text] [Related]
28. Clinical and microscopic predictors of Entamoeba histolytica intestinal infection in travelers and migrants diagnosed with Entamoeba histolytica/dispar infection.
Van Den Broucke S; Verschueren J; Van Esbroeck M; Bottieau E; Van den Ende J
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006892. PubMed ID: 30372434
[TBL] [Abstract][Full Text] [Related]
29. Detection of beta-tubulin in the cytoplasm of the interphasic Entamoeba histolytica trophozoites.
Gómez-Conde E; Vargas-Mejía MÁ; Díaz-Orea MA; Hernández-Rivas R; Cárdenas-Perea ME; Guerrero-González T; González-Barrios JA; Montiel-Jarquín ÁJ
Exp Parasitol; 2016 Aug; 167():38-42. PubMed ID: 27156446
[TBL] [Abstract][Full Text] [Related]
30. The lipophosphoglycan-like molecules of virulent and avirulent E. histolytica as well as of E. dispar differ in both composition and abundance.
Moody S; Becker S; Nuchamowitz Y; McConville MJ; Mirelman D
Arch Med Res; 1997; 28 Spec No():98-102. PubMed ID: 9033029
[No Abstract] [Full Text] [Related]
31. [Entamoeba histolytica and Entamoeba dispar: differentiation methods and implications].
Anane S; Khaled S
Ann Biol Clin (Paris); 2005; 63(1):7-13. PubMed ID: 15689308
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of Entamoeba histolytica and Entamoeba dispar patient isolates to human complement.
Walderich B; Weber A; Knobloch J
Parasite Immunol; 1997 Jun; 19(6):265-71. PubMed ID: 9364556
[TBL] [Abstract][Full Text] [Related]
33. Comparison of hemolytic activity of the intermediate subunit of Entamoeba histolytica and Entamoeba dispar lectins.
Kato K; Makiuchi T; Cheng X; Tachibana H
PLoS One; 2017; 12(7):e0181864. PubMed ID: 28750000
[TBL] [Abstract][Full Text] [Related]
34. [Differentiation of Entamoeba histolytica from Entamoeba dispar using Gal/GalNAc-lectin and polymerase chain reaction].
López OY; López MC; Corredor V; Echeverri MC; Pinilla AE
Rev Med Chil; 2012 Apr; 140(4):476-83. PubMed ID: 22854693
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of infection with Entamoeba dispar, but not E. histolytica, in captive macaques.
Tachibana H; Cheng XJ; Kobayashi S; Matsubayashi N; Gotoh S; Matsubayashi K
Parasitol Res; 2001 Jan; 87(1):14-7. PubMed ID: 11199843
[TBL] [Abstract][Full Text] [Related]
36. MALDI-TOF mass spectrometry for the detection and differentiation of Entamoeba histolytica and Entamoeba dispar.
Calderaro A; Piergianni M; Buttrini M; Montecchini S; Piccolo G; Gorrini C; Rossi S; Chezzi C; Arcangeletti MC; Medici MC; De Conto F
PLoS One; 2015; 10(4):e0122448. PubMed ID: 25874612
[TBL] [Abstract][Full Text] [Related]
37. Host-antibody inductivity of virulent Entamoeba histolytica and non-virulent Entamoeba moshkovskii in a mouse model.
Khomkhum N; Leetachewa S; Pawestri AR; Moonsom S
Parasit Vectors; 2019 Mar; 12(1):101. PubMed ID: 30867040
[TBL] [Abstract][Full Text] [Related]
38. Effect of dinitroaniline herbicides on the growth of Entamoeba histolytica.
Makioka A; Kumagai M; Ohtomo H; Kobayashi S; Takeuchi T
J Parasitol; 2000 Jun; 86(3):607-10. PubMed ID: 10864261
[TBL] [Abstract][Full Text] [Related]
39. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh.
Haque R; Faruque AS; Hahn P; Lyerly DM; Petri WA
J Infect Dis; 1997 Mar; 175(3):734-6. PubMed ID: 9041357
[TBL] [Abstract][Full Text] [Related]
40. Study of the trophozoite surface of Entamoeba histolytica with high resolution cytochemical studies and scanning electron microscopy.
Feria-Velasco A; Tapia-Arizmendi G; González-Del Pliego M
Arch Invest Med (Mex); 1980; 11(4):461-75. PubMed ID: 6260049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
